Principal Financial Group Inc. Sells 46,767 Shares of Chemed Corporation $CHE

Principal Financial Group Inc. lessened its position in Chemed Corporation (NYSE:CHE) by 59.1% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 32,364 shares of the company’s stock after selling 46,767 shares during the period. Principal Financial Group Inc. owned approximately 0.22% of Chemed worth $14,491,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Creekmur Asset Management LLC bought a new stake in shares of Chemed in the 2nd quarter valued at $28,000. First Horizon Corp bought a new position in shares of Chemed during the 3rd quarter valued at about $31,000. Pilgrim Partners Asia Pte Ltd acquired a new position in shares of Chemed in the 3rd quarter valued at approximately $45,000. Parkside Financial Bank & Trust increased its stake in Chemed by 86.3% during the 2nd quarter. Parkside Financial Bank & Trust now owns 95 shares of the company’s stock worth $46,000 after purchasing an additional 44 shares in the last quarter. Finally, HM Payson & Co. increased its stake in Chemed by 35.5% during the 3rd quarter. HM Payson & Co. now owns 103 shares of the company’s stock worth $46,000 after purchasing an additional 27 shares in the last quarter. 95.85% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on CHE shares. Jefferies Financial Group cut shares of Chemed from a “buy” rating to a “hold” rating in a report on Thursday, January 22nd. Zacks Research raised shares of Chemed from a “strong sell” rating to a “hold” rating in a research note on Thursday, October 30th. Royal Bank Of Canada dropped their price target on Chemed from $589.00 to $572.00 and set an “outperform” rating on the stock in a research note on Monday, November 10th. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Chemed in a report on Wednesday, January 21st. Three investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, Chemed currently has an average rating of “Moderate Buy” and an average target price of $555.50.

Insider Buying and Selling at Chemed

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of the business’s stock in a transaction on Monday, November 24th. The shares were sold at an average price of $437.55, for a total transaction of $875,100.00. Following the transaction, the chief executive officer directly owned 94,197 shares in the company, valued at approximately $41,215,897.35. The trade was a 2.08% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 3.29% of the company’s stock.

Chemed Price Performance

Chemed stock opened at $447.92 on Tuesday. The firm has a 50-day moving average of $437.01 and a 200-day moving average of $441.68. The company has a market cap of $6.34 billion, a price-to-earnings ratio of 23.69, a P/E/G ratio of 2.18 and a beta of 0.44. Chemed Corporation has a one year low of $408.42 and a one year high of $623.60.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.